2021
DOI: 10.3390/ijms22041967
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Ultra-Micronized-Palmitoylethanolamide and Acetyl-l-Carnitine on Experimental Model of Inflammatory Pain

Abstract: Palmitoylethanolamide (PEA), a fatty acid amide, has been widely investigated for its analgesic and anti-inflammatory properties. The ultra-micronized formulation of PEA (um-PEA), that has an enhanced rate of dissolution, is extensively used. Acetyl-l-carnitine (LAC), employed for the treatment of neuropathic pain in humans, is able to cause analgesia by up-regulating type-2 metabotropic glutamate (mGlu2) receptors. In the present study, we tested different associations of um-PEA, LAC and non-micronized PEA (n… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
19
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(23 citation statements)
references
References 28 publications
(18 reference statements)
0
19
0
Order By: Relevance
“…OEA inhibits MCP-1 levels ( Montecucco et al, 2015 ; Antón et al, 2017 ; Zhao et al, 2018 ) and also reduces TNF levels ( Sayd et al, 2014 ; Chen et al, 2015 ; Xu et al, 2016 ; Antón et al, 2017 ). PEA reduces MCP-1 levels ( D’Aloia et al, 2021 ; Fusco et al, 2021 ) and TNF levels ( Costa et al, 2008 ; De Filippis et al, 2009 ; Hoareau et al, 2009 ; Cerrato et al, 2010 ; Di Paola et al, 2012 , 2016 ; Sayd et al, 2014 ; Impellizzeri et al, 2015 ; Rahimi et al, 2015 ; Orefice et al, 2016 ; Britti et al, 2017 ; Gugliandolo et al, 2017 ; D’amico et al, 2019 ; Puglia et al, 2020 ; Ardizzone et al, 2021 ; D’Aloia et al, 2021 ). PEA reduces inflammation in human colonic tissue (from patients with IBD, colon cancer and appendicitis), including levels of IL-6, IL-8, IL-17A, MCP-1, and GM-CSF ( Couch et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…OEA inhibits MCP-1 levels ( Montecucco et al, 2015 ; Antón et al, 2017 ; Zhao et al, 2018 ) and also reduces TNF levels ( Sayd et al, 2014 ; Chen et al, 2015 ; Xu et al, 2016 ; Antón et al, 2017 ). PEA reduces MCP-1 levels ( D’Aloia et al, 2021 ; Fusco et al, 2021 ) and TNF levels ( Costa et al, 2008 ; De Filippis et al, 2009 ; Hoareau et al, 2009 ; Cerrato et al, 2010 ; Di Paola et al, 2012 , 2016 ; Sayd et al, 2014 ; Impellizzeri et al, 2015 ; Rahimi et al, 2015 ; Orefice et al, 2016 ; Britti et al, 2017 ; Gugliandolo et al, 2017 ; D’amico et al, 2019 ; Puglia et al, 2020 ; Ardizzone et al, 2021 ; D’Aloia et al, 2021 ). PEA reduces inflammation in human colonic tissue (from patients with IBD, colon cancer and appendicitis), including levels of IL-6, IL-8, IL-17A, MCP-1, and GM-CSF ( Couch et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…Immunohistochemical staining was performed as previously described [ 19 , 20 ] and reported below. The brains were removed, fixed and embedded in paraffin.…”
Section: Methodsmentioning
confidence: 99%
“…Phospho-α-syn (p-α-syn) and CD68 were evaluated on brain tissues extracts for each experimental group as previously described [ 20 ].…”
Section: Methodsmentioning
confidence: 99%
“…New insights such as these may allow for the design of targeted drugs for the treatment of peripheral neuropathies. Recent research on neuropathic pain and its pharmacological treatment resulted in the suggestion that compounds such as palmitoylethanolamide (and its derivatives), acetyl-l-carnitine, and berberine may be beneficial [ 39 , 40 , 41 , 42 , 43 ]. Hypotheses such as these may be complemented and advanced by experimental approaches based on human peripheral neurons.…”
Section: Introductionmentioning
confidence: 99%